My watch list
my.bionity.com  
Login  

Sanofi Canada invests in prostate cancer research

Collaboration with the GU Radiation Oncology Group of Quebec and the Segal Cancer Centre at the Jewish General Hospital (JGH)

CNW Group/SANOFI CANADA

02-05-2012: Sanofi Canada is supporting a five-year study on radiation therapy and prostate cancer. Dr. Tamim Niazi of the Quebec Radiation Oncology GU Group and the JGH is the lead researcher. Sanofi Canada President and CEO, Hugh O'Neill and members of Sanofi's Oncology Team celebrate the collaboration.

Watchlist

This is where you can add this news to your personal favourites

Facts, background information, dossiers
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE